Stammdaten
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
Unternehmen & Branche
| Name | HST Global, Inc. |
|---|---|
| Ticker | HSTC |
| CIK | 0000797564 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 40432E202 |
|---|---|
| ISIN | US40432E2028 |
| Typ | Common Stock |
| Marktkapitalisierung | 42,3 Mio. USD |
| Beta | -1,24 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2024-09-30 | 10-Q | 0 | -13,792 | 1,281,070 | 1,238,994 | |
| 2024-06-30 | 10-Q | 0 | -16,640 | 5,155 | -17,879 | |
| 2024-03-31 | 10-Q | 0 | -34,177 | 838 | -626,244 | |
| 2023-12-31 | 10-K | 0 | -146,210 | 1,526 | -592,067 | |
| 2023-09-30 | 10-Q | 0 | -35,730 | 2,000 | -555,168 | |
| 2023-06-30 | 10-Q | 0 | -34,295 | 2,320 | -519,438 | |
| 2023-03-31 | 10-Q | 0 | -39,286 | 115 | -485,143 | |
| 2022-12-31 | 10-K | 0 | -145,074 | 190 | -445,857 | |
| 2022-09-30 | 10-Q | 0 | -35,636 | 278 | -410,146 | |
| 2022-06-30 | 10-Q | 0 | -35,513 | 365 | -374,510 | |
| 2022-03-31 | 10-Q | 0 | -38,214 | 127 | -338,997 | |
| 2021-12-31 | 10-K | 0 | -148,360 | 225 | -300,783 | |
| 2021-09-30 | 10-Q | 0 | -35,340 | 523 | -265,381 | |
| 2021-06-30 | 10-Q | 0 | -38,879 | 1,121 | -230,041 | |
| 2021-03-31 | 10-Q | 0 | -38,740 | 0 | -191,163 | |
| 2020-12-31 | 10-K | 0 | -208,992 | 660 | -152,423 | |
| 2020-09-30 | 10-Q | 0 | -34,934 | 750 | -117,225 | |
| 2020-06-30 | 10-Q | 0 | -44,028 | 1,471 | -82,293 | |
| 2020-03-31 | 10-Q | 0 | -34,833 | 0 | -38,264 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-24 | 76 | 0,63 | 48 |
| 2026-03-23 | 76 | 0,63 | 48 |
| 2026-03-20 | 76 | 0,63 | 48 |
| 2026-03-10 | 124 | 0,50 | 62 |
| 2026-03-09 | 124 | 0,63 | 78 |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.